A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in Thailand
Completed
- Conditions
- DiabetesDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
- Registration Number
- NCT00805922
- Lead Sponsor
- Novo Nordisk A/S
- Brief Summary
This study is conducted in Asia. The aim of this observational study is to evaluate current status of diabetes management, control, complications in diabetic subjects in Thailand.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2342
Inclusion Criteria
- Diabetic patients registered in the particular centre for more than 12 months.
- Patients should have visited the centre at least once in the last 3-6 months apart from the initial visit.
- Patients willing to sign informed consent form.
Exclusion Criteria
- Repetition of any patient as patients should not be included twice for any reason.
- Unwilling to participate or unable to comply with protocol requirements.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean blood glucose parameters of diabetic patients Study start
- Secondary Outcome Measures
Name Time Method Patients' perception will be analysed through patient questionnaire measuring psychological well-being, quality of life and patients' compliant to treatment Study start Physician perception of diabetes and its management will be analysed through physician questionnaire measuring awareness about HbA1c test and its goal, anti-diabetic treatment and barriers towards optimum diabetes control Study start Duration of diabetes associated with highest number of diabetic complications Study start Minimum duration of diabetes associated with 10% incidence of diabetic complications (CVD, Nephropathy and retinopathy) Study start
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of insulin resistance in Type 2 diabetes patients in Thailand as studied in NCT00805922?
How does the DiabCare Asia 2008 survey compare the effectiveness of standard-of-care diabetes treatments in Thailand?
What biomarkers are associated with chronic complications in Type 1 and Type 2 diabetes patients in the NCT00805922 observational study?
What adverse events are reported in the Novo Nordisk A/S observational study of diabetes management in Thailand (NCT00805922)?
What combination therapies or competitor drugs are evaluated alongside diabetes management practices in the DiabCare Asia 2008 survey?
Trial Locations
- Locations (1)
Novo Nordisk Investigational Site
🇹🇭Bangkok, Thailand
Novo Nordisk Investigational Site🇹🇭Bangkok, Thailand